News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
486,370 Results
Type
Article (8077)
Company Profile (143)
Press Release (478149)
Multimedia
Podcasts (4)
Webinars (6)
Section
Business (166856)
Career Advice (304)
Deals (25753)
Drug Delivery (7)
Drug Development (52878)
Employer Resources (14)
FDA (9769)
Job Trends (8580)
News (238273)
Policy (17899)
Tag
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (3)
2027 Biotech Bay Standard (6)
2027 Biotech Beach Elite (1)
2027 Biotech Beach Standard (1)
2027 Genetown Elite (1)
2027 Genetown Standard (2)
2027 Pharm Country Digital (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (491)
Accelerated approval (26)
ADA (18)
Adcomms (1)
Allergies (98)
Alliances (33164)
ALS (114)
Alzheimer's disease (994)
Antibody-drug conjugate (ADC) (286)
Approvals (10427)
Artificial intelligence (342)
ASCO (159)
Autoimmune disease (224)
Automation (29)
Bankruptcy (263)
Belgium (2)
Best Places to Work (6957)
BIO (36)
Biologics (10)
BIOSECURE Act (1)
Biosimilars (116)
BioSpace Insights (18)
Biotechnology (90)
Bispecific (1)
Bladder cancer (140)
Brain cancer (31)
Breast cancer (521)
Cancer (3790)
Cardiovascular disease (227)
Career advice (243)
Career pathing (1)
CAR-T (180)
CDC (1)
CDMO (21)
Celiac Disease (1)
Cell therapy (493)
Cervical cancer (35)
Clinical research (48085)
Collaboration (1291)
Commercialization (3)
Compensation (1539)
Complete response letters (34)
COVID-19 (763)
CRISPR (64)
C-suite (814)
Cystic fibrosis (87)
Data (5917)
Denatured (4)
Depression (113)
Dermatology (71)
Diabetes (362)
Diagnostics (4226)
Digital health (39)
Diversity (1)
Diversity, equity & inclusion (4)
Drug discovery (160)
Drug pricing (7)
Drug shortages (2)
Duchenne muscular dystrophy (167)
Earnings (73773)
Editorial (3)
Employer branding (2)
Employer resources (14)
Events (88188)
Executive appointments (720)
FDA (12531)
Fibrodysplasia Ossificans Progressiva (9)
Friedreich's ataxia (19)
Frontotemporal dementia (24)
Funding (960)
Gene editing (126)
Generative AI (12)
Gene therapy (335)
GLP-1 (297)
Government (950)
Grass and pollen (2)
Guidances (281)
Healthcare (9377)
Hematology (94)
HIV (55)
Huntington's disease (25)
IgA nephropathy (70)
Immunology and inflammation (108)
Immuno-oncology (61)
Indications (164)
Infectious disease (955)
Inflammatory bowel disease (130)
Inflation Reduction Act (4)
Influenza (85)
Intellectual property (265)
Interviews (41)
IPO (12390)
IRA (2)
Job creations (1973)
Job search strategy (233)
JPM (2)
Kidney cancer (17)
Kidney disease (46)
Labor market (1)
Layoffs (63)
Legal (5194)
Licensing (20)
Liver cancer (45)
Longevity (20)
Lung cancer (549)
Lymphoma (259)
Machine learning (30)
Management (3)
Manufacturing (581)
Marketing (8)
MASH (118)
Medical affairs (2)
Medical device (8679)
Medtech (8839)
Mergers & acquisitions (14430)
Metabolic disorders (736)
mRNA (66)
Multiple sclerosis (107)
NASH (4)
Neurodegenerative disease (230)
Neuropsychiatric disorders (42)
Neuroscience (1898)
NextGen: Class of 2026 (3155)
Non-profit (845)
Obesity (234)
Opinion (10)
Ovarian cancer (163)
Pain (179)
Pancreatic cancer (207)
Parkinson's disease (208)
Partnered (12)
Patents (505)
Patient recruitment (535)
Patient selection (4)
Peanut (32)
People (41438)
Peptides (3)
Pharmaceutical (31)
Pharmacy benefit managers (9)
Phase 1 (15523)
Phase 2 (21481)
Phase 3 (14494)
Pipeline (7816)
Policy (18)
Postmarket research (1560)
Preclinical (6557)
Press Release (34)
Prostate cancer (193)
Psychedelics (8)
Radiopharmaceuticals (195)
Rare diseases (593)
Real estate (3038)
Recruiting (6)
Regenerative medicine (5)
Regulatory (14991)
Reports (23)
Research institute (590)
Resumes & cover letters (45)
Rett syndrome (42)
RNA editing (5)
RSV (48)
Schizophrenia (105)
Series A (166)
Series B (124)
Service/supplier (5)
Sickle cell disease (63)
Spinal muscular atrophy (91)
Sponsored (5)
Startups (2027)
Stomach cancer (3)
Substance use disorders (16)
Supply chain (51)
Vaccines (320)
Venture capital (17)
Weight loss (75)
Women's health (91)
Date
Last 7 days (293)
Last 30 days (1381)
Last 365 days (19031)
2026 (13922)
2025 (19268)
2024 (23013)
2023 (26568)
2022 (34598)
2021 (37189)
2020 (33492)
2019 (23283)
2018 (17511)
2017 (18797)
2016 (17940)
2015 (24280)
2014 (21685)
2013 (18139)
2012 (20229)
2011 (20432)
2010 (20334)
Location
Africa (228)
Alabama (81)
Alaska (2)
Arizona (312)
Arkansas (10)
Asia (17978)
Australia (2098)
California (12425)
Canada (3259)
China (553)
Colorado (505)
Connecticut (428)
Delaware (216)
Europe (24680)
Florida (1870)
Georgia (394)
Hawaii (3)
Idaho (46)
Illinois (734)
India (54)
Indiana (326)
Iowa (16)
Japan (431)
Kansas (104)
Kentucky (33)
Louisiana (28)
Maine (26)
Maryland (1238)
Massachusetts (8142)
Michigan (315)
Minnesota (573)
Mississippi (5)
Missouri (83)
Montana (20)
Nebraska (11)
Nevada (124)
New Hampshire (60)
New Jersey (2718)
New Mexico (12)
New York (2915)
North Carolina (1328)
North Dakota (4)
Northern California (6246)
Ohio (297)
Oklahoma (14)
Oregon (16)
Pennsylvania (2310)
Puerto Rico (23)
Rhode Island (30)
South America (403)
South Carolina (78)
South Dakota (1)
Southern California (5181)
Tennessee (127)
Texas (2030)
United States (40292)
Utah (377)
Vermont (1)
Virginia (161)
Washington D.C. (39)
Washington State (960)
West Virginia (2)
Wisconsin (76)
Wyoming (1)
486,370 Results for "ppd inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Thermo Fisher Scientific’s PPD Clinical Research Business Expands Bioanalytical Capabilities with New Laboratory in Gothenburg, Sweden
May 18, 2026
·
3 min read
Press Releases
Thermo Fisher Scientific’s PPD Clinical Research Business Collaborates with HealthVerity to Expand Real-World Data Capabilities
April 14, 2026
·
2 min read
Press Releases
Thermo Fisher Scientific Launches PPD CorEvitas Alzheimer’s Disease Registry to Advance Real-World Evidence in Neurodegenerative Care
December 19, 2025
·
3 min read
Press Releases
Reunion Neuroscience Presents Full Data from RECONNECT Phase 2 Clinical Trial of RE104 for the Treatment of Postpartum Depression (PPD) at ACNP Annual Meeting
January 20, 2026
·
5 min read
Business
Medidata and Thermo Fisher Scientific’s PPD Clinical Research Business Collaborate to Accelerate Clinical Trials Innovation
Medidata today announced it has renewed its relationship with the PPD clinical research business of Thermo Fisher Scientific Inc.
February 28, 2024
·
3 min read
Press Releases
Reunion Neuroscience Announces Positive Topline Results from RECONNECT Phase 2 Clinical Trial of RE104 for the Treatment of Postpartum Depression (PPD)
August 19, 2025
·
8 min read
Press Releases
Reunion Neuroscience Announces Last Patient Dosed in RECONNECT Phase 2 Clinical Trial of RE104 for the Treatment of Postpartum Depression (PPD)
May 19, 2025
·
4 min read
Drug Development
Thermo Fisher Scientific’s PPD Clinical Research Business Selected by BARDA to Support Phase II Platform Clinical Trial to Treat Acute Respiratory Distress Syndrome (ARDS)
The PPD clinical research business of Thermo Fisher Scientific Inc., the world leader in serving science, has been selected by the Biomedical Advanced Research and Development Authority (BARDA) to implement the first BARDA-supported Phase II platform clinical trial to investigate multiple therapeutic options for the treatment of acute respiratory distress syndrome (ARDS).
December 21, 2023
·
4 min read
Deals
Thermo Fisher Scientific Completes Acquisition of PPD, Inc.
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that it has completed its acquisition of PPD, Inc. (Nasdaq: PPD), a leading global provider of clinical research services to the biopharma and biotech industry, for $17.4 billion.
December 8, 2021
·
7 min read
Business
PPD Reports Third Quarter and Year-To-Date 2021 Results
PPD, Inc. (Nasdaq: PPD ), a leading global contract research organization, today reported its financial results for the third quarter ended September 30, 2021.
October 27, 2021
·
30 min read
1 of 48,637
Next
